Dave Wallace, Generics Bulletin executive editor (@davegenerics) 's Twitter Profile
Dave Wallace, Generics Bulletin executive editor

@davegenerics

Generics Bulletin editor Dave Wallace looks at everything that's important to the generics, biosimilars and value-added medicines industries. All views my own.

ID: 1106128939427205120

linkhttps://pharmaintelligence.informa.com/ calendar_today14-03-2019 09:44:24

129 Tweet

131 Followers

120 Following

Dave Wallace, Generics Bulletin executive editor (@davegenerics) 's Twitter Profile Photo
Dave Wallace, Generics Bulletin executive editor
@davegenerics

3 years ago

In an exclusive two-part interview, Samsung Bioepis development division leader Kyung-ah Kim and Biogen global head of biosimilars Ian Henshaw discuss how the firms are aiming to capitalize on their launch of the world’s first Lucentis biosimilar, Byooviz, in the US.